Annals of Emergency Medicine
Volume 50, Issue 5 , Pages 552-563 , November 2007

A Systematic Review of Medical Therapy to Facilitate Passage of Ureteral Calculi

  • Amandeep Singh, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Amandeep Singh, MD, Highland General Hospital, Department of Emergency Medicine, 1411 East 31st Street, Oakland, CA 94602; 510-437-4088, fax 510-437-8322
    • ,
  • Harrison J. Alter, MS, MD
    • ,
  • Amy Littlepage, MD

Received 8 February 2007 ,Revised 6 May 2007 ,Accepted 9 May 2007.

References 

  1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1964-1994. Kidney Int. 2003;63:1817–1823
  2. Sierakowski R, Finlayson B, Landes RR, et al. The frequency of urolithiasis in hospital discharge diagnosis in the United States. Invest Urol. 1978;15:438–441
  3. Pearle MS, Calhoun EA, Curhan GC UDAP. Urologic disease in America project: urolithiasis. J Urol. 2005;173:848–857
  4. Coe FL, Keck J, Norton ER. The natural history of calcium urolithiasis. JAMA. 1977;238:1519–1523
  5. Ueno A, Kawamura T, Ogawa A, et al. Relation of spontaneous passage of ureteral calculi to size. Urology. 1977;10:544–546
  6. Hubner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol. 1993;24:172–176
  7. Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999;162:688–691
  8. Segura JW, Preminger GM, Assimos DG, et al. Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. J Urol. 1997;158:1915–1921
  9. Papa L, Stiell IG, Wells GA, et al. Predicting intervention in renal colic patients after emergency department evaluation. Can J Emerg Med. 2005;7:78–86
  10. Morse RM, Resnick ML. Ureteral calculi: natural history and treatment in an era of advanced technology. J Urol. 1991;145:263–265
  11. Teichman JMH. Acute renal colic from ureteral calculus. N Engl J Med. 2004;350:684–693
  12. Davenport K, Timoney AG, Keeley FX. A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int. 2006;98:651–655
  13. Troxel SA, Jones AW, Magliola L, et al. Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol. 2006;20:565–568
  14. Hertle L, Nawrath H. Calcium channel blockade in smooth muscle of the human upper urinary tract I (Effects of depolarization-induced activation). J Urol. 1984;132:1265–1269
  15. Hertle L, Nawrath H. Calcium channel blockade in smooth muscle of the human upper urinary tract II (Effects of norepinepherine-induced activation). J Urol. 1984;132:1270–1274
  16. Peters HJ, Eckstein W. Possible pharmacological means of treating renal colic. Urol Res. 1975;4:55–59
  17. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet. 1999;354:1896–1900
  18. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet. 2001;357:1191–1194
  19. Jadad AR, Moore RA, Carrol S, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1–12
  20. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  21. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  22. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873–890
  23. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046–1055
  24. Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  25. Tobias A. sbe26: Assessing the influence of a single study in meta-analysis. Stata Tech Bull. 1999;47:15–17
  26. Ukhal’ MI, Malomuzh OI, Strashnyi VV, et al. The use of the alpha 1-adrenoblocker doxazosin in the pharmacotherapy of disorders of urine outflow of spastic origin. [in Russian] Lik Sprava. 1998;(8):118–121
  27. Pricop C, Novac C, Negru D, et al. Can selective alpha blockers help the spontaneous passage of stones located in the uretero-bladder junction?. Rev Med Chir Soc Med Nat Iasi. 2004;108:128–133
  28. Berenyi P, Feher J, Bognar F. The alpha-1-adrenoceptor blocker alfuzosin helps the spontaneous passage of distal ureteral stones. [abstract 128] Eur Urol Suppl. 2002;1:34
  29. Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin—simplified treatment regimen and health-related quality of life. Urology. 2005;66:712–715
  30. Porpiglia F, Destefanis P, Fiori C, et al. Role of adjunctive medical therapy with nifedipine and deflazacort after extracorporeal shock wave lithotripsy of ureteral stones. Urology. 2002;59:835–838
  31. Micheli C, Guiggi P, Balesta A, et al. Role of adjuvant therapy in stone expulsion after ESWL. [abstract 180] Eur Urol Suppl. 2005;4:47
  32. Gravina GL, Costa AM, Ronchi P, et al. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology. 2005;66:24–28
  33. Micali S, Celia A, Sighinolfi M, et al. Efficacy of expulsive medical therapy using nifedipine or tamsulosin after shock wave lithotripsy of ureteral stones. [abstract 177] Eur Urol Suppl. 2005;4:47
  34. Han MC, Jeong WS, Shim BS. Additive expulsion effect on tamsulosin after shock wave lithotripsy for upper ureteral stones. Korean J Urol. 2006;47:813–817
  35. Resim S, Ekerbicer HC, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology. 2005;66:945–948
  36. Cervenakov I, Fillo J, Mardiak J, et al. Speedy elimination of ureterolithiasis in lower part of ureters with the a1 blocker tamsulosin. Int Urol Nephrol. 2002;34:25–29
  37. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol. 2003;170:2202–2205
  38. Kupeli B, Irkilata L, Gurocak S, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology. 2004;64:1111–1115
  39. Porpiglia F, Ghignone G, Fiori C, et al. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol. 2004;172:568–571
  40. Tekin A, Aklan E, Beysel M, et al. Alpha 1 receptor blocking therapy for lower ureteral stones: a randomized prospective trial. [abstract 1152] J Urol. 2004;171(suppl 4):304
  41. Autorino R, De Sio M, Damiano R, et al. The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?. Urol Res. 2005;33:460–464
  42. Avdoshin VP, Andriukhin MI, Barabash MI, et al. Tamsulosin in the treatment of patients with uteroliths of the lower third of the ureter clinical and pharmacoeconomic grounds. Urologiia. 2005;(4):36–39
  43. Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine, and spasmolytic in medical expulsive therapy for distal ureteral calculi. J Urol. 2005;174:167–172
  44. Resim S, Ekerbicer H, Ciftci A. Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus. Int J Urol. 2005;12:615–620
  45. Taghavi R, Darabi MR, Tavakoli K, et al. Survey of the effect of tamsulosin and nifedipine on facilitating juxtavesical ureteral stone passage. [abstract MP03-06] J Endourol. 2005;19(suppl 1):A9
  46. Yilmaz E, Batislam E, Basar MM, et al. The comparison and efficacy of 3 different a1-adrenergic blockers for distal ureteral stones. J Urol. 2005;173:2010–2012
  47. De Sio M, Autorino R, Di Lorenzo G, et al. Medical expulsive treatment of distal ureteral stones using tamsulosin: a single center experience. J Endourol. 2006;20:12–16
  48. Han MC, Park YY, Shim BS. Effect of tamsulosin on the expectant treatment of lower ureteral stones. Korean J Urol. 2006;47:708–711
  49. Liatsikos E, Voudoukis T, Katsakiori P, et al. Doxazosin for the management of distal ureteral stones. [abstract 51] Eur Urol Suppl. 2006;5:35
  50. Mohseni MG, Hosseini SR, Alizadeh F. Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones. Saudi Med J. 2006;27:838–840
  51. Porpiglia F, Vaccino D, Billia M, et al. Corticosteroids and tamsulosin in the medical expulsive therapy of symptomatic distal ureter stones: single drug or association?. Eur Urol. 2006;50:339–344
  52. Borghi L, Meschi T, Amato F, et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol. 1994;152:1095–1100
  53. Cooper JT, Stack GM, Cooper TP. Intensive medical management of ureteral calculi. Urology. 2000;56:575–578
  54. Porpiglia F, Destefanis P, Fiori C, et al. Effectiveness of nifedipine and deflazacort in the management of distal ureteral stones. Urology. 2000;56:579–583
  55. Staerman F, Bryckaert PE, Colin J, et al. Nifedipine in the medical treatment of symptomatic distal ureteral calculi. 2000;15th Congress of the European Association of Urologists, Brussels, April 12-15
  56. Skrekas T, Liapis D, Kalantzis A, et al. Increasing the success rate of medical therapy for expulsion of distal ureteral stone using adjunctive treatment with calcium channel blocker. [abstract 317] Eur Urol Suppl. 2003;2:82
  57. Saita A, Bonaccorsi A, Marchese F, et al. Our experience with nifedipine and prednisolone as expulsive therapy for ureteral stones. Urol Int. 2004;72:43–45
  58. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med. 1997;337:536–542
  59. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046–1055
  60. Lau J, Ioannidis JPA, Terrin N, et al. The case of the misleading funnel plot. BMJ. 2006;333:597–600
  61. Krambeck AE, Gettman MT, Rohlinger AL, et al. Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of follow-up. J Urol. 2006;175:1742–1747
  62. Bierkens AF, Hendrixx AJ, De La Rosette JJ, et al. Treatment of mid- and lower ureteral calculi: extracorporeal shock wave lithotripsy vs. laser ureteroscopy (A comparison of costs, morbidity, and effectiveness). Br J Urol. 1998;81:31–35
  63. Rubin JI, Arger PH, Pollack HM, et al. Kidney changes after extracorporeal shock wave lithotripsy: CT evaluation. Radiology. 1987;162:21–24
  64. Harmon WJ, Serchon PD, Blute MI, et al. Ureteroscopy: current practice and long term complications. J Urol. 1997;157:28–32
  65. Schuster TG, Hollenbeck BK, Faerber GJ, et al. Complications of ureteroscopy: analysis of predictive factors. J Urol. 2001;166:538–540
  66. Daniels GF, Garnett JE, Carter MF. Ureterocopic results and complications: experience with 130 cases. J Urol. 1988;139:710–713
  67. El-Faqih SR, Husain I, Ekman PE, et al. Primary choice for intervention for distal ureteric stone: ureteroscopy of ESWL?. Br J Urol. 1988;62:13–18
  68. Kramolowsky EV. Ureteral perforation during ureterorenoscopy: treatment and management. J Urol. 1987;138:36–38
  69. Lotan Y, Gettman MT, Roehrborn CG, et al. Management of ureteral calculi: a cost comparison decision making analysis. J Urol. 2002;167:1621–1629
  70. Caravati EM, Runge JW, Bossart PJ, et al. Nifedipine for the relief of renal colic: a double-blind, placebo-controlled clinical trial. Ann Emerg Med. 1989;18:352–354
  71. McCormack M, Williot P, Lapointe S, et al. Nifedipine and ureteral colic. Ann Intern Med. 1986;104:590
  72. Coppens L, Lustman F. Nifedipine and ureteral colic. Ann Intern Med. 1986;105:967
  73. Bortolotti M, Trisolino G, Barbara L. Nifedipine in biliary and renal colic. JAMA. 1987;258:3516
  74. Carrol W. Nifedipine and ureteral colic. Ann Intern Med. 1985;102:864
  75. Lloret J, Vila A, Puig X, et al. Nifedipine in the treatment of renal colic. Methods Find Exp Clin Pharmacol. 1986;8:575–579
  76. Capecchi S, Pignatelli R, Alegiani F. Emergency treatment of ureteral colic with nifedipine. Minerva Urol Nephrol. 1991;43:287–291
  77. Basar I, Bircan K, Tasar C, et al. Diclofenac sodium and spasmolytic drugs in the treatment or ureteral colic: a comparative study. Int Urol Nephrol. 1991;23:227–230
  78. Hollingsworth JM, Rogers MAM, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006;368:1171–1179
  79. Pearle MS. Medical therapy for urinary stone passage. Lancet. 2006;368:1138–1139
  80. Anderson JK, Ogan K, Pearle MS. Ureteral calculi: improving stone passage rates with medical therapy. Contemp Urol. 2006;18:8–17
  81. Nuss GR, Rackley JD, Assimos DG. Adjunctive therapy to promote stone passage. Rev Urol. 2005;7:67–74
  82. Beach MA, Mauro LS. Pharmacologic expulsive treatment of ureteral calculi. Ann Pharmacother. 2006;20:1361–1368
  83. Healy KA, Organ K. Nonsurgical management of urolithiasis: an overview of expulsive therapy. J Endourol. 2005;19:759–767
  84. Michel MC, De la Rosette JJMCH. Alpha blocker treatment of urolithiasis. Eur Urol. 2006;50:213–214
  85. Debruyne FMJ. Alpha blockers: are all created equal?. Urology. 2000;56(suppl 5A):20–22
  86. O’Leary MP. Tamsulosin: current clinical experience. Urology. 2001;58(suppl 6a):42–48
  87. Roza TB, Bosch JLHR, Lock MTWT. Alpha 1-blockers and urolithiasis: a new cornerstone in the treatment of ureteral stones?. Nederlands Tijdschrift Urol. 2006;14:94–98
  88. Micali S, Grande M, Sighinolfi MC, et al. Medical therapy in urolithiasis. J Endourol. 2006;20:841–847
  89. Salehi M, Meher MF, Shiery H, et al. Does methylprednisolone acetate increase the success rate of medical therapy for passing distal ureteral stones?. BJU Int. 2004;94:278
  90. Bajor G. Beta-blocking agent for facilitating the spontaneous passage of ureteral stones. Int Urol Nephrol. 1990;22:33–36
  91. Hussain Z, Inman RD, Elves WS, et al. Use of glyceryl trinitrate patches in patients with ureteral stones: a randomized, double-blind, placebo-controlled study. Urology. 2001;58:521–525

 Supervising editor: Peter C. Wyer, MDFunding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.Publication dates: Available online August 3, 2007.Reprints not available from the authors.

PII: S0196-0644(07)00612-9

doi: 10.1016/j.annemergmed.2007.05.015

Annals of Emergency Medicine
Volume 50, Issue 5 , Pages 552-563 , November 2007

Article Tools

* Image Usage & Resolution